Hidradenitis suppurativa and Down syndrome in a single-centre sample: A cross-sectional study.
Down syndrome
IHS4
acne inversa
dermatology
hidradenitis suppurativa
Journal
The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
revised:
20
04
2022
received:
05
03
2022
accepted:
04
05
2022
pubmed:
15
5
2022
medline:
17
8
2022
entrez:
14
5
2022
Statut:
ppublish
Résumé
Down syndrome (DS) has been related to a higher risk of hidradenitis suppurativa (HS). This cross-sectional study assessed DS patients with HS in a Spanish single-centre sample. DS participants presented a lower age of onset, age at diagnosis and time to diagnosis. Also, DS was not associated with the severity of HS measured by baseline IHS
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e231-e237Informations de copyright
© 2022 The Australasian College of Dermatologists.
Références
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. J Am Acad Dermatol. 2020;82(5):1045-58. https://doi.org/10.1016/j.jaad.2019.08.090
Lam M, Lai C, Almuhanna N, Alhusayen R. Hidradenitis suppurativa and Down syndrome: a systematic review and meta-analysis. Pediatr Dermatol. 2020;37(6):1044-50. https://doi.org/10.1111/pde.14326
Jfri A, Nassim D, O'Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of hidradenitis suppurativa. JAMA Dermatol. 2021;157(8):924-31. https://doi.org/10.1001/jamadermatol.2021.1677
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, et al. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022;86(5):1092-101. https://doi.org/10.1016/j.jaad.2021.01.059
Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177(5):1401-9. https://doi.org/10.1111/bjd.15748
Giovanardi G, Chiricozzi A, Bianchi L, De Simone C, Dini V, Franceschini C, et al. Hidradenitis suppurativa associated with Down syndrome is characterized by early age at diagnosis. Dermatology. 2018;234(1-2):66-70. https://doi.org/10.1159/000487799
Prens EP, Lugo-Somolinos AM, Paller AS, Kerdel F, Duan Y, Teixeira HD, et al. Baseline characteristics from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa (acne inversa) in clinical practice. Am J Clin Dermatol. 2020;21(4):579-90. https://doi.org/10.1007/s40257-020-00504-4
Mebazaa A, Ben Hadid R, Cheikh Rouhou R, Trojjet S, El Euch D, Mokni M, et al. Hidradenitis suppurativa: a debilitating disease with male predominance in Tunisia. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(4):165-72.
Napolitano M, Mastroeni S, Fusari R, Mazzanti C, Ciccone D, Pallotta S, et al. The International Hidradenitis Suppurativa Severity Score System (IHS4) is a valuable tool to assess sex- and gender-associated differences. Eur J Dermatol. 2020;30(2):201-3. https://doi.org/10.1684/ejd.2020.3743
Denny G, Anadkat MJ. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset. J Am Acad Dermatol. 2016;75(3):632-4. https://doi.org/10.1016/j.jaad.2016.04.045